(Philadelphia, PA) - Muredach P. Reilly, MB, has been named Assistant Professor of Medicine, Division of Cardiovascular Medicine, at the University of Pennsylvania School of Medicine.

Dr. Reilly, a native of Ireland, earned his M.B., B.Ch., and BAO degrees from the School of Medicine at University College Dublin in Ireland. He went on to receive his BS in Pharmacology from the same university. From 1990-1994, he completed his residency in Medicine and his cardiovascular diseases clinical/research fellowship at Mater Hospital, Dublin, Ireland. In 1994, he began his residency, training in Medicine at the Hospital of the University of Pennsylvania (HUP) and in 2000, he completed his fellowship in HUP's Cardiovascular Division. He is presently in the Clinical Epidemiology and Biostatistics Masters training program at Penn.

Dr. Reilly's clinical interests focus on preventive cardiology, vascular medicine, diabetic cardiovascular disease and non-invasive cardiovascular imaging, specifically as it relates to sub-clinical atherosclerosis. His research interests include studying protein Kinase C in atherosclerosis; inflammation, metabolic syndrome and atherosclerosis; genetics of atherosclerotic cardiovascular diseases - particularly in type 2 diabetes; and magnetic resonance (MR) characterization of atherosclerosis in vivo.

He is certified by the American Board of Internal Medicine and the American Board of Internal Medicine, Cardiovascular. He has been the recipient of several accolades including the American College of Cardiology Fellows Award, Cardiovascular Fellow Teaching Award from the University of Pennsylvania and the Merck Young Investigator Award. Dr. Reilly is also an affiliate member of the American College of Cardiology, a member of the American Heart Association, the Society of Vascular Medicine and Biology, and the Royal College of Physicians in Ireland.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.